Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulatory T Cells: Regulation of Identity and Function.
Grover P, Goel PN, Greene MI. Grover P, et al. Front Immunol. 2021 Oct 5;12:750542. doi: 10.3389/fimmu.2021.750542. eCollection 2021. Front Immunol. 2021. PMID: 34675933 Free PMC article. Review.
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway.
Jia Y, Kodumudi KN, Ramamoorthi G, Basu A, Snyder C, Wiener D, Pilon-Thomas S, Grover P, Zhang H, Greene MI, Mo Q, Tong Z, Chen YZ, Costa RLB, Han H, Lee C, Soliman H, Conejo-Garcia JR, Koski G, Czerniecki BJ. Jia Y, et al. Among authors: grover p. Mol Ther. 2021 Apr 7;29(4):1541-1556. doi: 10.1016/j.ymthe.2020.12.037. Epub 2021 Jan 5. Mol Ther. 2021. PMID: 33412308 Free PMC article.
PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity.
Goel PN, Grover P, Greene MI. Goel PN, et al. Among authors: grover p. Crit Rev Immunol. 2020;40(4):283-295. doi: 10.1615/CritRevImmunol.2020034789. Crit Rev Immunol. 2020. PMID: 33426818 Review.
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma.
Ramamoorthi G, Kodumudi K, Snyder C, Grover P, Zhang H, Greene MI, Basu A, Gallen C, Wiener D, Costa RLB, Han HS, Koski G, Czerniecki BJ. Ramamoorthi G, et al. Among authors: grover p. J Immunother Cancer. 2022 Jun;10(6):e004841. doi: 10.1136/jitc-2022-004841. J Immunother Cancer. 2022. PMID: 35710296 Free PMC article.
Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer.
Goel PN, Zhang H, Murali R, Zheng C, Ji MQ, Patterson A, Grover P, Greene M. Goel PN, et al. Among authors: grover p. Biochem Biophys Res Commun. 2023 Apr 9;651:39-46. doi: 10.1016/j.bbrc.2023.02.019. Epub 2023 Feb 9. Biochem Biophys Res Commun. 2023. PMID: 36791497
657 results